RETROVIRAL ENV-MEDIATED LEUKEMOGENESIS (MEETING ABSTRACT) NLM AIDSLINE Important note: Information in this article was accurate in 1992. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


RETROVIRAL ENV-MEDIATED LEUKEMOGENESIS (MEETING ABSTRACT)

Fifteenth Symposium of the International Association for Comparative Research on Leukemia and Related Diseases. October 6-11, 1991, Padova/Venice, Italy, p. 3, 1991.. Unique Identifier : AIDSLINE ICDB/92682362
Amanuma H; Watanabe N; Ikawa Y; Tsukuba Life Science Center, RIKEN, Tsukuba, Ibaraki 305, Japan


Abstract: Friend spleen focus-forming virus (SFFV), originally isolated as one of the components of the Friend virus complex, is a member of the murine replication-defective type C retroviruses and induces acute, progressive erythroleukemia, called Friend disease, in adult mice. In the early stage, enhanced polyclonal proliferation of the erythroid progenitor cells occurs in the spleen of the infected mouse. The glycoprotein (gp55) encoded by the defective env gene of SFFV is responsible for this polyclonal proliferation. This gp55 gene alone induces the disease in transgenic mice. gp55 was reported to bind Epo-receptor to support IL-3-dependent cell growth, and especially sends signals dependent on this receptor. We performed extensive mutational analyses on the primary structure-biochemical property and biological activity relationship of gp55 in the polycythemia-inducing strain of SFFV using in vitro constructed mutants and the revertants isolated in vivo after the pathogenic selection. When the intracytoplasmic tail of gp55 is longer than 10 amino acids, the modified gp55 molecules cannot be released from the cells, and the reconstructed SFFV variants become nonleukemogenic. We present the results of these studies and discuss the mechanism of action of gp55 in the modulation of the function of the erythropoietin receptor. Recently, a murine Mink cell-focusing virus, env, was found to send signals to the IL-2 receptor (LI, J-P et al, personal communication) and UV-inactivated HTLV-1 particles showed mitogenic function (Gazzolo L et al, personal communication). These studies may initiate retroviral env-mediated leukemogenesis. (5 Refs)
Keywords: Animal Cell Division Erythroid Progenitor Cells/CYTOLOGY Gene Products, env/*GENETICS HTLV-I/GENETICS Leukemia, Experimental/*GENETICS Mice Mice, Transgenic Mink Cell Focus-Inducing Viruses/GENETICS Mitogens Receptors, Cell Surface/METABOLISM Receptors, Interleukin-2/GENETICS Spleen Focus-Forming Viruses/*GENETICS ABSTRACTKWDanimalcelldivisionerythroidprogenitorcells/cytologygeneproducts,env/KWDgeneticshtlv-i/geneticsleukemia,experimental/KWDgeneticsmicemice,transgenicminkcellfocus-inducingviruses/geneticsmitogensreceptors,cellsurface/metabolismreceptors,interleukin-2/geneticsspleenfocus-formingviruses/KWDgeneticsabstract
920830
M9281113

Copyright © 1992 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1992. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1992. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .